Europe Cough Syrup Market Forecast 2023-2032

The Europe cough syrup market is projected to register a CAGR of 3.64% during the forecast period, 2023-2032. European consumers' inclination toward self-medication has exerted a notable influence on the cough syrup industry, influencing consumer preferences and behaviors. The growing awareness, ease of access, and preference for convenience have led to a rising trend in self-medication for common respiratory ailments, resulting in several noteworthy implications for the cough syrup sector.

MARKET INSIGHTS

Italy, Spain, France, the United Kingdom, Belgium, Poland, Germany, and Rest of Europe are evaluated for the Europe cough syrup market growth assessment. The demand for cough syrups in Germany is significantly affected by the prevailing self-medication trends. Germany's healthcare system, known for its accessibility and emphasis on personal responsibility, promotes self-care for minor health issues, including common respiratory problems like coughs and colds. Consequently, German consumers are increasingly opting for over-the-counter (OTC) remedies, such as cough syrups, as their initial choice for managing these symptoms.

One of the key drivers behind this shift is the convenience and availability of OTC medications throughout Germany. Cough syrups are easily accessible in pharmacies and retail outlets, enabling consumers to purchase them without requiring a doctor's prescription.

Furthermore, the rising practice of self-medication in Italy is anticipated to boost the need for cough syrups domestically. Italians are increasingly adopting a proactive approach to handling their well-being, especially for minor health issues such as coughs and colds. Consequently, over-the-counter (OTC) cough syrups have gained favor as a self-care option, leading to their increasing appeal. The convenience offered by OTC medications aligns seamlessly with Italy's ethos of self-sufficiency and personal accountability in healthcare.

COMPETITIVE INSIGHTS

Some of the leading companies in the market are: Abbott Laboratories, Novartis AG, Acella Pharmaceuticals, etc.

Our report offerings include:

Explore key findings of the overall market
Strategic breakdown of market dynamics (Drivers, Restraints, Opportunities, Challenges)
Market forecasts for a minimum of 9 years, along with 3 years of historical data for all segments, sub-segments, and regions
Market Segmentation caters to a thorough assessment of key segments with their market estimations
Geographical Analysis: Assessments of the mentioned regions and country-level segments with their market share
Key analytics: Porter's Five Forces Analysis, Vendor Landscape, Opportunity Matrix, Key Buying Criteria, etc.
The competitive landscape is the theoretical explanation of the key companies based on factors, market share, etc.
Company profiling: A detailed company overview, product/services offered, SCOT analysis, and recent strategic developments

Product Code: 71429

1. RESEARCH SCOPE & METHODOLOGY

1.1. STUDY OBJECTIVES
1.2. METHODOLOGY
1.3. ASSUMPTIONS & LIMITATIONS

2. EXECUTIVE SUMMARY

2.1. MARKET SIZE & ESTIMATES
2.2. MARKET OVERVIEW
2.3. SCOPE OF STUDY
2.4. CRISIS SCENARIO ANALYSIS
- 2.4.1. IMPACT OF COVID-19 ON COUGH SYRUP MARKET
- 2.4.2. IMPACT OF THE RUSSIA-UKRAINE WAR ON COUGH SYRUP MARKET
2.5. MAJOR MARKET FINDINGS
- 2.5.1. PRODUCT DIVERSIFICATION IS ON THE RISE
- 2.5.2. DOMINANCE OF OTC COUGH SYRUPS HAS DRIVEN ACCESSIBILITY
- 2.5.3. HEALTHCARE INFORMATION AVAILABILITY ON DIGITAL PLATFORMS INFLUENCES CONSUMER CHOICES

3. MARKET DYNAMICS

3.1. KEY DRIVERS
- 3.1.1. PREVALENCE OF RESPIRATORY AILMENTS
- 3.1.2. RISING GERIATRIC POPULATION
- 3.1.3. INNOVATIONS IN COUGH SYRUPS
3.2. KEY RESTRAINTS
- 3.2.1. OVER-DOSAGE CONCERNS DRIVING CONSUMERS TOWARD ALTERNATIVES
- 3.2.2. STRINGENT REGULATORY PROTOCOLS
- 3.2.3. INCREASING CASES OF COUGH SYRUP DEATHS

4. KEY ANALYTICS

4.1. KEY MARKET TRENDS
- 4.1.1. INCREASING SELF-MEDICATION TRENDS
- 4.1.2. SHIFTING CONSUMER PREFERENCE TOWARD HERBAL COUGH SYRUPS
- 4.1.3. RISING POPULARITY OF E-COMMERCE CHANNELS
- 4.1.4. COMPANIES ARE OFFERING SUGAR-FREE COUGH SYRUPS
- 4.1.5. GROWING INCLINATION TOWARD HOMEOPATHIC COUGH SYRUPS
4.2. PORTER'S FIVE FORCES ANALYSIS
- 4.2.1. BUYERS POWER
- 4.2.2. SUPPLIERS POWER
- 4.2.3. SUBSTITUTION
- 4.2.4. NEW ENTRANTS
- 4.2.5. INDUSTRY RIVALRY
4.3. GROWTH PROSPECT MAPPING
- 4.3.1. GROWTH PROSPECT MAPPING FOR ITALY
4.4. VALUE CHAIN ANALYSIS

5. MARKET BY PRODUCT TYPE

5.1. COUGH SUPPRESSANTS
- 5.1.1. MARKET FORECAST FIGURE
- 5.1.2. SEGMENT ANALYSIS
5.2. COMBINATION MEDICINES
- 5.2.1. MARKET FORECAST FIGURE
- 5.2.2. SEGMENT ANALYSIS
5.3. EXPECTORANTS
- 5.3.1. MARKET FORECAST FIGURE
- 5.3.2. SEGMENT ANALYSIS

6. MARKET BY AGE GROUP

6.1. ADULTS
- 6.1.1. MARKET FORECAST FIGURE
- 6.1.2. SEGMENT ANALYSIS
6.2. ADOLESCENTS
- 6.2.1. MARKET FORECAST FIGURE
- 6.2.2. SEGMENT ANALYSIS
6.3. PEDIATRIC
- 6.3.1. MARKET FORECAST FIGURE
- 6.3.2. SEGMENT ANALYSIS

7. MARKET BY DISTRIBUTION CHANNEL

7.1. RETAIL PHARMACIES
- 7.1.1. MARKET FORECAST FIGURE
- 7.1.2. SEGMENT ANALYSIS
7.2. HOSPITAL PHARMACIES
- 7.2.1. MARKET FORECAST FIGURE
- 7.2.2. SEGMENT ANALYSIS
7.3. E-PHARMACIES
- 7.3.1. MARKET FORECAST FIGURE
- 7.3.2. SEGMENT ANALYSIS

8. GEOGRAPHICAL ANALYSIS

8.1. EUROPE
- 8.1.1. MARKET SIZE & ESTIMATES
- 8.1.2. EUROPE COUGH SYRUP MARKET DRIVERS
- 8.1.3. EUROPE COUGH SYRUP MARKET CHALLENGES
- 8.1.4. EUROPE COUGH SYRUP MARKET REGULATORY FRAMEWORK
- 8.1.5. KEY PLAYERS IN EUROPE COUGH SYRUP MARKET
- 8.1.6. COUNTRY ANALYSIS
  - 8.1.6.1. UNITED KINGDOM
  - 8.1.6.1.1. UNITED KINGDOM COUGH SYRUP MARKET SIZE & OPPORTUNITIES
  - 8.1.6.2. GERMANY
  - 8.1.6.2.1. GERMANY COUGH SYRUP MARKET SIZE & OPPORTUNITIES
  - 8.1.6.3. FRANCE
  - 8.1.6.3.1. FRANCE COUGH SYRUP MARKET SIZE & OPPORTUNITIES
  - 8.1.6.4. ITALY
  - 8.1.6.4.1. ITALY COUGH SYRUP MARKET SIZE & OPPORTUNITIES
  - 8.1.6.5. SPAIN
  - 8.1.6.5.1. SPAIN COUGH SYRUP MARKET SIZE & OPPORTUNITIES
  - 8.1.6.6. POLAND
  - 8.1.6.6.1. POLAND COUGH SYRUP MARKET SIZE & OPPORTUNITIES
  - 8.1.6.7. BELGIUM
  - 8.1.6.7.1. BELGIUM COUGH SYRUP MARKET SIZE & OPPORTUNITIES
  - 8.1.6.8. REST OF EUROPE
  - 8.1.6.8.1. REST OF EUROPE COUGH SYRUP MARKET SIZE & OPPORTUNITIES

9. COMPETITIVE LANDSCAPE

9.1. KEY STRATEGIC DEVELOPMENTS
- 9.1.1. MERGERS & ACQUISITIONS
- 9.1.2. PRODUCT LAUNCHES & DEVELOPMENTS
- 9.1.3. PARTNERSHIPS & AGREEMENTS
- 9.1.4. BUSINESS EXPANSIONS & DIVESTITURES
9.2. COMPANY PROFILES
- 9.2.1. ABBOTT LABORATORIES
  - 9.2.1.1. COMPANY OVERVIEW
  - 9.2.1.2. PRODUCT LIST
  - 9.2.1.3. STRENGTHS & CHALLENGES
- 9.2.2. ACELLA PHARMACEUTICALS
  - 9.2.2.1. COMPANY OVERVIEW
  - 9.2.2.2. PRODUCT LIST
  - 9.2.2.3. STRENGTHS & CHALLENGES
- 9.2.3. ASTRAZENECA PLC
  - 9.2.3.1. COMPANY OVERVIEW
  - 9.2.3.2. PRODUCT LIST
  - 9.2.3.3. STRENGTHS & CHALLENGES
- 9.2.4. CIPLA LTD
  - 9.2.4.1. COMPANY OVERVIEW
  - 9.2.4.2. PRODUCT LIST
  - 9.2.4.3. STRENGTHS & CHALLENGES
- 9.2.5. DABUR INDIA LTD
  - 9.2.5.1. COMPANY OVERVIEW
  - 9.2.5.2. PRODUCT LIST
  - 9.2.5.3. STRENGTHS & CHALLENGES
- 9.2.6. GLENMARK PHARMACEUTICALS LTD
  - 9.2.6.1. COMPANY OVERVIEW
  - 9.2.6.2. PRODUCT LIST
  - 9.2.6.3. STRENGTHS & CHALLENGES
- 9.2.7. GSK PLC
  - 9.2.7.1. COMPANY OVERVIEW
  - 9.2.7.2. PRODUCT LIST
  - 9.2.7.3. STRENGTHS & CHALLENGES
- 9.2.8. HIMALAYA WELLNESS COMPANY
  - 9.2.8.1. COMPANY OVERVIEW
  - 9.2.8.2. PRODUCT LIST
  - 9.2.8.3. STRENGTHS & CHALLENGES
- 9.2.9. KENVUE
  - 9.2.9.1. COMPANY OVERVIEW
  - 9.2.9.2. PRODUCT LIST
  - 9.2.9.3. STRENGTHS & CHALLENGES
- 9.2.10. MERCK KGAA
  - 9.2.10.1. COMPANY OVERVIEW
  - 9.2.10.2. PRODUCT LIST
  - 9.2.10.3. STRENGTHS & CHALLENGES
- 9.2.11. NOVARTIS AG
  - 9.2.11.1. COMPANY OVERVIEW
  - 9.2.11.2. PRODUCT LIST
  - 9.2.11.3. STRENGTHS & CHALLENGES
- 9.2.12. PFIZER INC
  - 9.2.12.1. COMPANY OVERVIEW
  - 9.2.12.2. PRODUCT LIST
  - 9.2.12.3. STRENGTHS & CHALLENGES
- 9.2.13. PROCTER & GAMBLE
  - 9.2.13.1. COMPANY OVERVIEW
  - 9.2.13.2. PRODUCT LIST
  - 9.2.13.3. STRENGTHS & CHALLENGES
- 9.2.14. RECKITT BENCKISER GROUP PLC
  - 9.2.14.1. COMPANY OVERVIEW
  - 9.2.14.2. PRODUCT LIST
  - 9.2.14.3. STRENGTHS & CHALLENGES
- 9.2.15. SANOFI
  - 9.2.15.1. COMPANY OVERVIEW
  - 9.2.15.2. PRODUCT LIST
  - 9.2.15.3. STRENGTHS & CHALLENGES

Product Code: 71429

LIST OF TABLES

TABLE 1: MARKET SNAPSHOT - COUGH SYRUP MARKET
TABLE 2: EUROPE COUGH SYRUP MARKET, BY PRODUCT TYPE, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)
TABLE 3: EUROPE COUGH SYRUP MARKET, BY PRODUCT TYPE, FORECAST YEARS, 2023-2032 (IN $ MILLION)
TABLE 4: EUROPE COUGH SYRUP MARKET, BY AGE GROUP, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)
TABLE 5: EUROPE COUGH SYRUP MARKET, BY AGE GROUP, FORECAST YEARS, 2023-2032 (IN $ MILLION)
TABLE 6: EUROPE COUGH SYRUP MARKET, BY DISTRIBUTION CHANNEL, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)
TABLE 7: EUROPE COUGH SYRUP MARKET, BY DISTRIBUTION CHANNEL, FORECAST YEARS, 2023-2032 (IN $ MILLION)
TABLE 8: EUROPE COUGH SYRUP MARKET, BY COUNTRY, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)
TABLE 9: EUROPE COUGH SYRUP MARKET, BY COUNTRY, FORECAST YEARS, 2023-2032 (IN $ MILLION)
TABLE 10: EUROPE COUGH SYRUP MARKET REGULATORY FRAMEWORK
TABLE 11: KEY PLAYERS OPERATING IN EUROPE COUGH SYRUP MARKET
TABLE 12: LIST OF MERGERS & ACQUISITIONS
TABLE 13: LIST OF PRODUCT LAUNCHES & DEVELOPMENTS
TABLE 14: LIST OF PARTNERSHIPS & AGREEMENTS
TABLE 15: LIST OF BUSINESS EXPANSIONS & DIVESTITURES

LIST OF FIGURES

FIGURE 1: KEY MARKET TRENDS
FIGURE 2: PORTER'S FIVE FORCES ANALYSIS
FIGURE 3: GROWTH PROSPECT MAPPING FOR ITALY
FIGURE 4: VALUE CHAIN ANALYSIS
FIGURE 5: EUROPE COUGH SYRUP MARKET, GROWTH POTENTIAL, BY PRODUCT TYPE, IN 2022
FIGURE 6: EUROPE COUGH SYRUP MARKET, BY COUGH SUPPRESSANTS, 2023-2032 (IN $ MILLION)
FIGURE 7: EUROPE COUGH SYRUP MARKET, BY COMBINATION MEDICINES, 2023-2032 (IN $ MILLION)
FIGURE 8: EUROPE COUGH SYRUP MARKET, BY EXPECTORANTS, 2023-2032 (IN $ MILLION)
FIGURE 9: EUROPE COUGH SYRUP MARKET, GROWTH POTENTIAL, BY AGE GROUP, IN 2022
FIGURE 10: EUROPE COUGH SYRUP MARKET, BY ADULTS, 2023-2032 (IN $ MILLION)
FIGURE 11: EUROPE COUGH SYRUP MARKET, BY ADOLESCENTS, 2023-2032 (IN $ MILLION)
FIGURE 12: EUROPE COUGH SYRUP MARKET, BY PEDIATRIC, 2023-2032 (IN $ MILLION)
FIGURE 13: EUROPE COUGH SYRUP MARKET, GROWTH POTENTIAL, BY DISTRIBUTION CHANNEL, IN 2022
FIGURE 14: EUROPE COUGH SYRUP MARKET, BY RETAIL PHARMACIES, 2023-2032 (IN $ MILLION)
FIGURE 15: EUROPE COUGH SYRUP MARKET, BY HOSPITAL PHARMACIES, 2023-2032 (IN $ MILLION)
FIGURE 16: EUROPE COUGH SYRUP MARKET, BY E-PHARMACIES, 2023-2032 (IN $ MILLION)
FIGURE 17: EUROPE COUGH SYRUP MARKET, COUNTRY OUTLOOK, 2022 & 2032 (IN %)
FIGURE 18: UNITED KINGDOM COUGH SYRUP MARKET, 2023-2032 (IN $ MILLION)
FIGURE 19: GERMANY COUGH SYRUP MARKET, 2023-2032 (IN $ MILLION)
FIGURE 20: FRANCE COUGH SYRUP MARKET, 2023-2032 (IN $ MILLION)
FIGURE 21: ITALY COUGH SYRUP MARKET, 2023-2032 (IN $ MILLION)
FIGURE 22: SPAIN COUGH SYRUP MARKET, 2023-2032 (IN $ MILLION)
FIGURE 23: POLAND COUGH SYRUP MARKET, 2023-2032 (IN $ MILLION)
FIGURE 24: BELGIUM COUGH SYRUP MARKET, 2023-2032 (IN $ MILLION)
FIGURE 25: REST OF EUROPE COUGH SYRUP MARKET, 2023-2032 (IN $ MILLION)